Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse von Hu, Rachel, Wei, Wei, Mian, Agrima, Gonter‐Aubin, Kristen, Kabel, Charlene, Mato, Anthony, Stephens, Deborah M., Hanlon, Ashley, Khajavian, Sirin, Shadman, Mazyar, Brander, Danielle, Madanat, Yazan, Park, Jae H., Tallman, Martin, Pinilla‐Ibarz, Javier, Hill, Brian T.

Volltext

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis von Gonter-Aubin, Kristen, Kerr, Daniel Alan, Rose, Ashley, Nguyen, Thanh Lana, Chavez, Julio C., Pinilla Ibarz, Javier

Volltext

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Single-Institution Analysis von Kerr, Daniel Alan, Gonter-Aubin, Kristen, Rose, Ashley, Nguyen, Thanh Lana, Pinilla Ibarz, Javier, Chavez, Julio C.

Volltext

Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia Patients at First Relapse: A Multi-Center Outcomes Analysis von Hu, Rachel, Wei, Wei, Gonter-Aubin, Kristen, Pinilla Ibarz, Javier, Kabel, Charlene C., Mato, Anthony R., Madanat, Yazan F., Khajavian, Sirin, Shadman, Mazyar, Hanlon, Ashley, Brander, Danielle M., Park, Jae H., Tallman, Martin S., Hill, Brian T.

Volltext

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective, Single-Institution Analysis von Rose, Ashley, Kerr, Daniel, Kristen, Gonter-Aubin, Thanh, Afiat, Julio, Chavez, Javier, Pinilla-Ibarz

Volltext